 | • レポートコード：MRC2312MG09307 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学＆材料 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のチアムリン原薬市場規模と予測を収録しています。・世界のチアムリン原薬市場：売上、2018年-2023年、2024年-2029年 ・世界のチアムリン原薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のチアムリン原薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「獣医用」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 チアムリン原薬のグローバル主要企業は、Shanxi New Energy Huakang、 Sunny Biotech、 Hebei Weiyuan、 Baoding Jizhong Pharmaceutical Industry、 Terra Pharmaceuticals、 China Animal Husbandry Co., Ltd.、 Shandong Victory Biotechnology、 Lukang Medicine、 Aqua Pharma、 Huvepharma、 Sandoz、 Sanfovetなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、チアムリン原薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のチアムリン原薬市場：タイプ別、2018年-2023年、2024年-2029年 世界のチアムリン原薬市場：タイプ別市場シェア、2022年 ・獣医用、人間用 世界のチアムリン原薬市場：用途別、2018年-2023年、2024年-2029年 世界のチアムリン原薬市場：用途別市場シェア、2022年 ・研究、製薬、その他 世界のチアムリン原薬市場：地域・国別、2018年-2023年、2024年-2029年 世界のチアムリン原薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるチアムリン原薬のグローバル売上、2018年-2023年 ・主要企業におけるチアムリン原薬のグローバル売上シェア、2022年 ・主要企業におけるチアムリン原薬のグローバル販売量、2018年-2023年 ・主要企業におけるチアムリン原薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Shanxi New Energy Huakang、 Sunny Biotech、 Hebei Weiyuan、 Baoding Jizhong Pharmaceutical Industry、 Terra Pharmaceuticals、 China Animal Husbandry Co., Ltd.、 Shandong Victory Biotechnology、 Lukang Medicine、 Aqua Pharma、 Huvepharma、 Sandoz、 Sanfovet ************************************************************* ・調査・分析レポートの概要 チアムリン原薬市場の定義 市場セグメント 世界のチアムリン原薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のチアムリン原薬市場規模 世界のチアムリン原薬市場規模：2022年 VS 2029年 世界のチアムリン原薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのチアムリン原薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のチアムリン原薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：獣医用、人間用 チアムリン原薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：研究、製薬、その他 チアムリン原薬の用途別グローバル売上・予測 ・地域別市場分析 地域別チアムリン原薬市場規模 2022年と2029年 地域別チアムリン原薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Shanxi New Energy Huakang、 Sunny Biotech、 Hebei Weiyuan、 Baoding Jizhong Pharmaceutical Industry、 Terra Pharmaceuticals、 China Animal Husbandry Co., Ltd.、 Shandong Victory Biotechnology、 Lukang Medicine、 Aqua Pharma、 Huvepharma、 Sandoz、 Sanfovet ... |
This research report provides a comprehensive analysis of the Tiamulin API market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Tiamulin API market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Tiamulin API, challenges faced by the industry, and potential opportunities for market players.
The global Tiamulin API market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Tiamulin API market presents opportunities for various stakeholders, including Research, Pharmaceutical. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Tiamulin API market. Additionally, the growing consumer demand present avenues for market expansion.
The global Tiamulin API market was valued at US$ 108.5 million in 2022 and is projected to reach US$ 145 million by 2029, at a CAGR of 4.2% during the forecast period.
The chemical industry market is a broad and diverse economic sector covering the production, processing, distribution and application of chemical products. This market includes all aspects from raw material supply to final product manufacturing, covering a wide range of fields, including petrochemicals, pesticides, fertilizers, plastics, coatings, chemical fibers, medicine, etc. The chemical market plays a key role in various industries, providing essential chemical products for energy, manufacturing, agriculture, medical, construction and consumer goods, among others. The market competition is fierce, and it is constantly evolving and developing under the influence of environmental protection regulations, technological innovation and market demand. As awareness of sustainability and environmental protection increases, the chemical market is increasingly focusing on green and sustainable solutions to meet the needs of global society. Therefore, the chemical industry market is an important economic field with a significant impact on the development of various industries and the global economy.
Key Features:
The research report on the Tiamulin API market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Tiamulin API market.
Market Overview: The report provides a comprehensive overview of the Tiamulin API market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Veterinary Use, Human Use), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Tiamulin API market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Tiamulin API market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Tiamulin API market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Tiamulin API market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Tiamulin API market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Tiamulin API market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Tiamulin API, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Tiamulin API market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Tiamulin API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Veterinary Use
Human Use
Market segment by Application
Research
Pharmaceutical
Other
Global Tiamulin API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Shanxi New Energy Huakang
Sunny Biotech
Hebei Weiyuan
Baoding Jizhong Pharmaceutical Industry
Terra Pharmaceuticals
China Animal Husbandry Co., Ltd.
Shandong Victory Biotechnology
Lukang Medicine
Aqua Pharma
Huvepharma
Sandoz
Sanfovet
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tiamulin API, market overview.
Chapter 2: Global Tiamulin API market size in revenue and volume.
Chapter 3: Detailed analysis of Tiamulin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tiamulin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Tiamulin API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Tiamulin API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tiamulin API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tiamulin API Overall Market Size
2.1 Global Tiamulin API Market Size: 2022 VS 2029
2.2 Global Tiamulin API Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Tiamulin API Sales: 2018-2029
3 Company Landscape
3.1 Top Tiamulin API Players in Global Market
3.2 Top Global Tiamulin API Companies Ranked by Revenue
3.3 Global Tiamulin API Revenue by Companies
3.4 Global Tiamulin API Sales by Companies
3.5 Global Tiamulin API Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Tiamulin API Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Tiamulin API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tiamulin API Players in Global Market
3.8.1 List of Global Tier 1 Tiamulin API Companies
3.8.2 List of Global Tier 2 and Tier 3 Tiamulin API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Tiamulin API Market Size Markets, 2022 & 2029
4.1.2 Veterinary Use
4.1.3 Human Use
4.2 By Type – Global Tiamulin API Revenue & Forecasts
4.2.1 By Type – Global Tiamulin API Revenue, 2018-2023
4.2.2 By Type – Global Tiamulin API Revenue, 2024-2029
4.2.3 By Type – Global Tiamulin API Revenue Market Share, 2018-2029
4.3 By Type – Global Tiamulin API Sales & Forecasts
4.3.1 By Type – Global Tiamulin API Sales, 2018-2023
4.3.2 By Type – Global Tiamulin API Sales, 2024-2029
4.3.3 By Type – Global Tiamulin API Sales Market Share, 2018-2029
4.4 By Type – Global Tiamulin API Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Tiamulin API Market Size, 2022 & 2029
5.1.2 Research
5.1.3 Pharmaceutical
5.1.4 Other
5.2 By Application – Global Tiamulin API Revenue & Forecasts
5.2.1 By Application – Global Tiamulin API Revenue, 2018-2023
5.2.2 By Application – Global Tiamulin API Revenue, 2024-2029
5.2.3 By Application – Global Tiamulin API Revenue Market Share, 2018-2029
5.3 By Application – Global Tiamulin API Sales & Forecasts
5.3.1 By Application – Global Tiamulin API Sales, 2018-2023
5.3.2 By Application – Global Tiamulin API Sales, 2024-2029
5.3.3 By Application – Global Tiamulin API Sales Market Share, 2018-2029
5.4 By Application – Global Tiamulin API Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Tiamulin API Market Size, 2022 & 2029
6.2 By Region – Global Tiamulin API Revenue & Forecasts
6.2.1 By Region – Global Tiamulin API Revenue, 2018-2023
6.2.2 By Region – Global Tiamulin API Revenue, 2024-2029
6.2.3 By Region – Global Tiamulin API Revenue Market Share, 2018-2029
6.3 By Region – Global Tiamulin API Sales & Forecasts
6.3.1 By Region – Global Tiamulin API Sales, 2018-2023
6.3.2 By Region – Global Tiamulin API Sales, 2024-2029
6.3.3 By Region – Global Tiamulin API Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Tiamulin API Revenue, 2018-2029
6.4.2 By Country – North America Tiamulin API Sales, 2018-2029
6.4.3 US Tiamulin API Market Size, 2018-2029
6.4.4 Canada Tiamulin API Market Size, 2018-2029
6.4.5 Mexico Tiamulin API Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Tiamulin API Revenue, 2018-2029
6.5.2 By Country – Europe Tiamulin API Sales, 2018-2029
6.5.3 Germany Tiamulin API Market Size, 2018-2029
6.5.4 France Tiamulin API Market Size, 2018-2029
6.5.5 U.K. Tiamulin API Market Size, 2018-2029
6.5.6 Italy Tiamulin API Market Size, 2018-2029
6.5.7 Russia Tiamulin API Market Size, 2018-2029
6.5.8 Nordic Countries Tiamulin API Market Size, 2018-2029
6.5.9 Benelux Tiamulin API Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Tiamulin API Revenue, 2018-2029
6.6.2 By Region – Asia Tiamulin API Sales, 2018-2029
6.6.3 China Tiamulin API Market Size, 2018-2029
6.6.4 Japan Tiamulin API Market Size, 2018-2029
6.6.5 South Korea Tiamulin API Market Size, 2018-2029
6.6.6 Southeast Asia Tiamulin API Market Size, 2018-2029
6.6.7 India Tiamulin API Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Tiamulin API Revenue, 2018-2029
6.7.2 By Country – South America Tiamulin API Sales, 2018-2029
6.7.3 Brazil Tiamulin API Market Size, 2018-2029
6.7.4 Argentina Tiamulin API Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Tiamulin API Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Tiamulin API Sales, 2018-2029
6.8.3 Turkey Tiamulin API Market Size, 2018-2029
6.8.4 Israel Tiamulin API Market Size, 2018-2029
6.8.5 Saudi Arabia Tiamulin API Market Size, 2018-2029
6.8.6 UAE Tiamulin API Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Shanxi New Energy Huakang
7.1.1 Shanxi New Energy Huakang Company Summary
7.1.2 Shanxi New Energy Huakang Business Overview
7.1.3 Shanxi New Energy Huakang Tiamulin API Major Product Offerings
7.1.4 Shanxi New Energy Huakang Tiamulin API Sales and Revenue in Global (2018-2023)
7.1.5 Shanxi New Energy Huakang Key News & Latest Developments
7.2 Sunny Biotech
7.2.1 Sunny Biotech Company Summary
7.2.2 Sunny Biotech Business Overview
7.2.3 Sunny Biotech Tiamulin API Major Product Offerings
7.2.4 Sunny Biotech Tiamulin API Sales and Revenue in Global (2018-2023)
7.2.5 Sunny Biotech Key News & Latest Developments
7.3 Hebei Weiyuan
7.3.1 Hebei Weiyuan Company Summary
7.3.2 Hebei Weiyuan Business Overview
7.3.3 Hebei Weiyuan Tiamulin API Major Product Offerings
7.3.4 Hebei Weiyuan Tiamulin API Sales and Revenue in Global (2018-2023)
7.3.5 Hebei Weiyuan Key News & Latest Developments
7.4 Baoding Jizhong Pharmaceutical Industry
7.4.1 Baoding Jizhong Pharmaceutical Industry Company Summary
7.4.2 Baoding Jizhong Pharmaceutical Industry Business Overview
7.4.3 Baoding Jizhong Pharmaceutical Industry Tiamulin API Major Product Offerings
7.4.4 Baoding Jizhong Pharmaceutical Industry Tiamulin API Sales and Revenue in Global (2018-2023)
7.4.5 Baoding Jizhong Pharmaceutical Industry Key News & Latest Developments
7.5 Terra Pharmaceuticals
7.5.1 Terra Pharmaceuticals Company Summary
7.5.2 Terra Pharmaceuticals Business Overview
7.5.3 Terra Pharmaceuticals Tiamulin API Major Product Offerings
7.5.4 Terra Pharmaceuticals Tiamulin API Sales and Revenue in Global (2018-2023)
7.5.5 Terra Pharmaceuticals Key News & Latest Developments
7.6 China Animal Husbandry Co., Ltd.
7.6.1 China Animal Husbandry Co., Ltd. Company Summary
7.6.2 China Animal Husbandry Co., Ltd. Business Overview
7.6.3 China Animal Husbandry Co., Ltd. Tiamulin API Major Product Offerings
7.6.4 China Animal Husbandry Co., Ltd. Tiamulin API Sales and Revenue in Global (2018-2023)
7.6.5 China Animal Husbandry Co., Ltd. Key News & Latest Developments
7.7 Shandong Victory Biotechnology
7.7.1 Shandong Victory Biotechnology Company Summary
7.7.2 Shandong Victory Biotechnology Business Overview
7.7.3 Shandong Victory Biotechnology Tiamulin API Major Product Offerings
7.7.4 Shandong Victory Biotechnology Tiamulin API Sales and Revenue in Global (2018-2023)
7.7.5 Shandong Victory Biotechnology Key News & Latest Developments
7.8 Lukang Medicine
7.8.1 Lukang Medicine Company Summary
7.8.2 Lukang Medicine Business Overview
7.8.3 Lukang Medicine Tiamulin API Major Product Offerings
7.8.4 Lukang Medicine Tiamulin API Sales and Revenue in Global (2018-2023)
7.8.5 Lukang Medicine Key News & Latest Developments
7.9 Aqua Pharma
7.9.1 Aqua Pharma Company Summary
7.9.2 Aqua Pharma Business Overview
7.9.3 Aqua Pharma Tiamulin API Major Product Offerings
7.9.4 Aqua Pharma Tiamulin API Sales and Revenue in Global (2018-2023)
7.9.5 Aqua Pharma Key News & Latest Developments
7.10 Huvepharma
7.10.1 Huvepharma Company Summary
7.10.2 Huvepharma Business Overview
7.10.3 Huvepharma Tiamulin API Major Product Offerings
7.10.4 Huvepharma Tiamulin API Sales and Revenue in Global (2018-2023)
7.10.5 Huvepharma Key News & Latest Developments
7.11 Sandoz
7.11.1 Sandoz Company Summary
7.11.2 Sandoz Business Overview
7.11.3 Sandoz Tiamulin API Major Product Offerings
7.11.4 Sandoz Tiamulin API Sales and Revenue in Global (2018-2023)
7.11.5 Sandoz Key News & Latest Developments
7.12 Sanfovet
7.12.1 Sanfovet Company Summary
7.12.2 Sanfovet Business Overview
7.12.3 Sanfovet Tiamulin API Major Product Offerings
7.12.4 Sanfovet Tiamulin API Sales and Revenue in Global (2018-2023)
7.12.5 Sanfovet Key News & Latest Developments
8 Global Tiamulin API Production Capacity, Analysis
8.1 Global Tiamulin API Production Capacity, 2018-2029
8.2 Tiamulin API Production Capacity of Key Manufacturers in Global Market
8.3 Global Tiamulin API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tiamulin API Supply Chain Analysis
10.1 Tiamulin API Industry Value Chain
10.2 Tiamulin API Upstream Market
10.3 Tiamulin API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tiamulin API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
